MFDS
- Status: likely_approved
🇰🇷 Dihydroergocriptine in South Korea
Dihydroergocriptine (dihydroergocryptine) regulatory status in South Korea.
Marketing authorisation
Dihydroergocriptine in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in South Korea
Frequently asked questions
Is Dihydroergocriptine approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Dihydroergocriptine in South Korea?
Marketing authorisation holder not available in our data.